[CH:1]([NH:4][C:5]1[CH:11]=[CH:10][C:9]([C:12]2[O:13][C:14]3[CH:20]=[CH:19][CH:18]=[CH:17][C:15]=3[N:16]=2)=[CH:8][C:6]=1[NH2:7])([CH3:3])[CH3:2].Cl.[C:22](=N)(OC)[CH3:23].C(=O)([O-])O.[Na+]>CO>[O:13]1[C:14]2[CH:20]=[CH:19][CH:18]=[CH:17][C:15]=2[N:16]=[C:12]1[C:9]1[CH:10]=[CH:11][C:5]2[N:4]([CH:1]([CH3:3])[CH3:2])[C:22]([CH3:23])=[N:7][C:6]=2[CH:8]=1To a methanol (5 mL) solution of 2-(2-isopropylaminoanilin-5-yl)benzoxazole (see Working Example 80-2) (180 mg, 0.673 mmol) was added methyl acetimidate hydrochloride (111 mg, 1.01 mmol), and this was heated to reflux for 2 hours. After the reaction was complete, saturated aqueous sodium hydrogen carbonate solution was added, and this was extracted with ethyl acetate. After the organic layer obtained was dried over anhydrous sodium sulfate, it was filtered and concentrated. The crystals obtained were purified by silica gel column chromatography to yield the title compound (196 mg, quant.) as white crystals.